Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of single-dose subcutaneous PN20 in chronic liver disease-associated thrombocytopenia before elective invasive procedures
CTR20251442Phase 2Active
- Sponsor
- Chongqing Paijin Biotechnology
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PJ004 in thrombocytopenia associated with chronic liver disease, sponsored by Chongqing Paijin Biotechnology. Started Jun 2025; status: active.
02
Drugs
PJ004
03
Conditions
thrombocytopenia associated with chronic liver disease
Beyond the preview
Go deeper on CTR20251442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251442.